New Step-by-Step care model aims to halt psychosis in its tracks
NCT ID NCT03970005
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a step-based care model for 100 people aged 12-25 who are at high risk for psychosis. Participants start with low-intensity support and move to stronger treatments only if needed, with the goal of reaching remission. Researchers will track symptom relief and quality of life over two years to see if this tailored approach helps prevent full-blown psychosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Step-Based Care Model (behavioral intervention)
- What this could lead to
- If successful, this approach could provide an effective way to manage early psychosis risk and prevent progression to full psychosis.
- What could go wrong
- This is a small, early-stage study with no control group, so results may not apply broadly. The intervention is complex and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRODROMAL SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
OSU Harding Hospital
Columbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain training from home: could a smartphone app sharpen thinking in early psychosis?
- Can a quick brain zap ease schizophrenia symptoms?
- Could a common antioxidant ease early psychosis symptoms?
- Could a brain booster stop schizophrenia before it starts?
- Can family therapy prevent psychosis in At-Risk youth?
- Brain training may boost social skills in at-risk teens